Status:
COMPLETED
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
HIV Infection
Pregnancy
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Access to highly active antiretroviral therapy can improve maternal health outcomes for the 4000 HIV- infected women who give birth daily and nearly eliminate transmission of HIV to their infants. How...
Detailed Description
Perinatal antiretroviral therapy dramatically reduces the risk of transmission of HIV to the 1.4 million infants born annually to HIV-infected mothers. Single-dose and single-drug strategies lead to i...
Eligibility Criteria
Inclusion
- Study was conducted and intervention was implemented in antenatal clinics. Criteria for clinic participation:
- Clinic providing antenatal services within greater Gaborone, Botswana
- CD4 specimens analyzed at Botswana Harvard HIV Reference Laboratory
- Supervising authority provided written permission for participation
Exclusion
- Facilities caring for incarcerated women
- Facilities without a dedicated antenatal program
- Endpoints assessed in pregnant women meeting the following criteria:
- Inclusion Criteria:
- Delivered at Princess Marina Hospital
- Documented HIV infection
- Botswana citizen
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
422 Patients enrolled
Trial Details
Trial ID
NCT01836003
Start Date
July 1 2011
End Date
October 1 2012
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Botswana Harvard AIDS Institute
Gaborone, Botswana